Zinc Deficiency (Acrodermatitis Enteropathica)

Overview

Plain-Language Overview

Zinc Deficiency (Acrodermatitis Enteropathica) is a rare inherited disorder that affects the body's ability to absorb zinc, an essential mineral important for many bodily functions. This condition primarily impacts the skin, immune system, and growth. People with this disorder often develop a distinctive rash around the mouth, hands, and feet, along with symptoms like diarrhea and hair loss. Because zinc is crucial for healing and fighting infections, affected individuals may experience frequent infections and delayed wound healing. The condition usually appears in infancy or early childhood and requires lifelong management to prevent complications.

Clinical Definition

Zinc Deficiency (Acrodermatitis Enteropathica) is an autosomal recessive disorder caused by mutations in the SLC39A4 gene, which encodes a zinc transporter responsible for intestinal zinc absorption. The core pathology is impaired zinc uptake leading to systemic zinc deficiency, which disrupts numerous zinc-dependent enzymatic processes. Clinically, it presents with a triad of periorificial and acral dermatitis, alopecia, and diarrhea. The deficiency impairs immune function, resulting in increased susceptibility to infections. Diagnosis is significant because untreated zinc deficiency can cause severe growth retardation, neuropsychological symptoms, and increased morbidity. Early recognition and zinc supplementation are critical to prevent life-threatening complications.

Inciting Event

Weaning from breast milk to zinc-poor formula or diet triggers symptom onset in genetically predisposed infants.
Onset may be precipitated by infections or increased metabolic demand that depletes zinc stores.
Initiation of total parenteral nutrition without zinc supplementation can trigger deficiency.

Latency Period

Symptoms typically develop within weeks to months after weaning from breast milk.
In cases of acquired deficiency, symptoms may appear within 1 to 3 months of inadequate zinc intake.
Congenital cases manifest in early infancy but may be delayed if zinc intake is sufficient initially.

Diagnostic Delay

Misattribution of skin lesions to eczema, seborrheic dermatitis, or atopic dermatitis delays diagnosis.
Lack of awareness of zinc deficiency as a cause of periorificial and acral dermatitis contributes to delay.
Failure to recognize the triad of acrodermatitis, alopecia, and diarrhea leads to missed diagnosis.
Normal initial serum zinc levels may occur due to acute phase response, complicating diagnosis.

Patient Population

Infants and young children typically present after weaning from breast milk due to decreased zinc bioavailability.
Both males and females are equally affected due to autosomal recessive inheritance.
More common in populations with limited dietary zinc intake or high prevalence of SLC39A4 mutations.

Risk Factors

Autosomal recessive inheritance of SLC39A4 mutations is the primary risk factor for acrodermatitis enteropathica.
Prematurity and exclusive breastfeeding without zinc supplementation increase risk due to low zinc stores and intake.
Malabsorption syndromes such as cystic fibrosis or chronic diarrhea can exacerbate zinc deficiency.
Total parenteral nutrition without adequate zinc supplementation predisposes to deficiency.
Chronic alcoholism and dietary zinc deficiency are less common but relevant risk factors.

Clinical Presentation

Signs & Symptoms

Periorificial and acral dermatitis with erythema, scaling, and vesicles
Diarrhea due to impaired intestinal mucosa
Alopecia with hair loss and brittle hair
Irritability and impaired wound healing
Growth retardation in infants and children

History of Present Illness

Initial presentation includes periorificial and acral erythematous, vesiculobullous, and crusted dermatitis.
Progressive alopecia and diarrhea develop as zinc deficiency worsens.
Patients often report poor appetite, irritability, and growth retardation.
Recurrent infections such as pneumonia or candidiasis may be present due to immune dysfunction.

Past Medical History

History of prematurity or exclusive breastfeeding without zinc supplementation is common.
Previous episodes of dermatitis or failure to thrive may be documented.
No prior significant illnesses unless complicated by secondary infections.
Family history of similar symptoms or known genetic zinc transporter defects may be noted.

Family History

Positive family history of acrodermatitis enteropathica due to autosomal recessive inheritance of SLC39A4 mutations.
Consanguinity increases risk of affected offspring.
Siblings may have similar presentations or be asymptomatic carriers.

Physical Exam Findings

Erythematous, scaly plaques with crusting and vesicles typically around the mouth, anus, and extremities
Alopecia with sparse, brittle hair
Glossitis characterized by a smooth, red tongue
Paronychia and nail dystrophy
Periorificial dermatitis with sharply demarcated borders

Diagnostic Workup

Diagnostic Criteria

Diagnosis is established by clinical presentation of characteristic periorificial and acral dermatitis, alopecia, and diarrhea in an infant or young child. Laboratory findings include low serum zinc levels and reduced alkaline phosphatase activity. Confirmation is supported by genetic testing identifying mutations in the SLC39A4 gene. A rapid clinical response to oral zinc supplementation further supports the diagnosis.

Pathophysiology

Key Mechanisms

Impaired intestinal zinc absorption due to mutations in the SLC39A4 gene encoding the ZIP4 transporter causes systemic zinc deficiency.
Zinc deficiency disrupts numerous zinc-dependent enzymes and transcription factors critical for skin integrity, immune function, and wound healing.
Loss of zinc-dependent metalloproteinase activity impairs epidermal barrier maintenance, leading to characteristic acrodermatitis.
Deficient zinc impairs lymphocyte function and cell-mediated immunity, increasing susceptibility to infections.
Reduced zinc availability disrupts DNA synthesis and cell proliferation, contributing to growth retardation and alopecia.

Involvement	Details
Organs	Skin is the primary organ affected, manifesting with periorificial and acral dermatitis.
Organs	Intestine is involved in zinc absorption; mutations in the SLC39A4 gene impair intestinal zinc uptake causing systemic deficiency.
Tissues	Epidermal tissue is prominently involved, showing characteristic vesiculobullous and eczematous lesions in acrodermatitis enteropathica.
Cells	Keratinocytes are affected by zinc deficiency leading to impaired skin barrier and characteristic dermatitis.
Cells	T lymphocytes show impaired function in zinc deficiency, contributing to immunodeficiency and increased infection risk.
Chemical Mediators	Zinc is a critical cofactor for numerous enzymes and transcription factors essential for DNA synthesis, cell division, and immune response.
Chemical Mediators	Alkaline phosphatase activity decreases in zinc deficiency, serving as a biochemical marker of zinc status.

Treatments

Pharmacological Treatments

Oral Zinc Supplementation
- Mechanism:
  - Replenishes systemic zinc levels to correct deficiency and restore enzymatic and immune functions.
- Side effects:
  - Gastrointestinal upset
  - Metallic taste
  - Nausea
- Clinical role:
  - First-line

Non-pharmacological Treatments

Nutritional counseling to ensure adequate dietary intake of zinc-rich foods such as meat, shellfish, and legumes.
Skin care with gentle emollients to manage acrodermatitis and prevent secondary infections.

Prevention

Pharmacological Prevention

Oral zinc supplementation is the mainstay for prevention and treatment
Parenteral zinc administration in cases of malabsorption
Avoidance of zinc chelators or antagonists during supplementation
Monitoring and adjusting zinc dose to maintain normal serum levels
Supplementation of other micronutrients if coexisting deficiencies are present

Non-pharmacological Prevention

Ensuring adequate dietary zinc intake through meat, seafood, and fortified cereals
Screening for and managing malabsorption syndromes early
Avoiding prolonged total parenteral nutrition without zinc
Educating at-risk populations about nutritional balance
Regular monitoring of growth and development in infants and children

Outcome & Complications

Complications

Secondary bacterial infections of skin lesions
Impaired immune function leading to increased infection risk
Delayed wound healing
Growth retardation and developmental delay in children
Neurologic symptoms such as hypogeusia and cognitive impairment

Short-term Sequelae	Long-term Sequelae
Acute dermatitis flare-ups with painful skin lesions Diarrhea and dehydration Secondary skin infections Irritability and lethargy Transient immune dysfunction	Chronic skin changes including lichenification and pigmentation alterations Persistent growth retardation if untreated in childhood Neurocognitive deficits due to prolonged deficiency Recurrent infections from sustained immune compromise Permanent alopecia in severe cases

Differential Diagnoses

Zinc Deficiency (Acrodermatitis Enteropathica) versus Essential Fatty Acid Deficiency

Zinc Deficiency (Acrodermatitis Enteropathica)	Essential Fatty Acid Deficiency
Periorificial and acral dermatitis with sharply demarcated erythematous plaques	Generalized dry, scaly dermatitis often involving trunk and extremities
Low serum zinc levels	Low serum linoleic acid and other essential fatty acids
Improvement with zinc supplementation	Improvement with dietary supplementation of essential fatty acids

Zinc Deficiency (Acrodermatitis Enteropathica) versus Biotin Deficiency

Zinc Deficiency (Acrodermatitis Enteropathica)	Biotin Deficiency
Neurologic symptoms are less prominent or absent	Prominent neurological symptoms including depression, lethargy, and paresthesias
Characteristic periorificial and acral dermatitis	Erythematous, scaly dermatitis mainly on the face, perineum, and extremities
Low serum zinc concentration	Low biotinidase activity or low serum biotin levels

Zinc Deficiency (Acrodermatitis Enteropathica) versus Atopic Dermatitis

Zinc Deficiency (Acrodermatitis Enteropathica)	Atopic Dermatitis
Usually presents in infancy or early childhood but with acute onset related to zinc deficiency	Typically begins in infancy or early childhood with chronic relapsing course
Predominantly periorificial and acral involvement without lichenification	Flexural areas commonly involved with lichenification
No atopic history; associated with systemic zinc deficiency signs	Often associated with personal or family history of atopy (asthma, allergic rhinitis)

Zinc Deficiency (Acrodermatitis Enteropathica) versus Cystic Fibrosis-related Zinc Deficiency

Zinc Deficiency (Acrodermatitis Enteropathica)	Cystic Fibrosis-related Zinc Deficiency
No history of pulmonary or pancreatic disease	History of chronic pulmonary infections and pancreatic insufficiency
Normal sweat chloride test; genetic testing shows SLC39A4 mutations	Positive sweat chloride test or genetic testing for CFTR mutations
Zinc supplementation alone leads to full resolution	Zinc supplementation improves symptoms but underlying CF requires additional management

Zinc Deficiency (Acrodermatitis Enteropathica) versus Pellagra (Niacin Deficiency)

Zinc Deficiency (Acrodermatitis Enteropathica)	Pellagra (Niacin Deficiency)
Non-photosensitive periorificial and acral dermatitis	Photosensitive dermatitis with symmetric, hyperpigmented, scaly plaques on sun-exposed areas
Neurologic symptoms are uncommon	Dementia, depression, and diarrhea (the 3 Ds of pellagra)
Low serum zinc levels	Low serum niacin or its metabolites